The DGE 3rd Real World Evidence & Market Access Summit offers insights into the latest clinical trial developments, AI trends, and new governmental regulations and policies associated with real world evidence (RWE). Experts will throw light on how regulatory decision-making can be enhanced with RWE. Attendees can also navigate the scope of AI and RWE collaboration in the healthcare landscape. Industry veterans will discuss the importance of RWE for success in clinical trials and enhanced patient outcomes.
To know more, please visit https://ibn.fm/8NcxG